Open Journal Systems

Cover Image

Efficacy of cinnamon in the treatment of orofacial conditions

C. P. Godwi Femine, E. Tatu Joy, M. Shashi Kiran


Background: Cinnamon is a spice which has been in use for 1000 of years for its taste, condiment, and for its medicinal values. It has a history of medicinal use in China, Egypt, and Europe. In traditional medicine, cinnamon is used in respiratory, digestive, and skin ailments. It has anti-inflammatory, antibacterial, antidiabetic, antiarthritic, anticlotting, and immune regulatory properties. Cinnamon oil is used topically in the treatment of certain skin diseases such as acne, eczema, and pimples. In recent times, there has been a gradual rise in interest in the use and research on medicinal plants the world over due to their safety margin and minimal side and adverse effects. Aim: This paper aims to review the available scientific literature and to provide a comprehensive summary on the potential medicinal benefits of cinnamon in orofacial disease conditions. A review of the scientific literature available on cinnamon conclusively proves its efficacy in the management of several ailments including metabolic disorders like diabetes and lifestyle-associated conditions like hyperlipidemia. Conclusion: A review of its mechanism of action indicates its potential therapeutic benefit in the management of various orofacial conditions including trigeminal neuralgia and lichen planus. Clinical Significance: Cinnamon unfortunately like any medications does have its share of adverse effects and reactions, and therefore, its clinical use must be paved with caution and planned clinical trials, keeping in mind its potential adverse effects and interactions will result in a more standard formulation and protocol for the use of cinnamon as a therapeutic agent.


Antioxidants; Cinnamomum zeylanicum; diabetes mellitus; immunity; immunomodulators; oral health

Full Text:



Maheshwari RK, Chauhan AK, Gupta A, Sharma S. Cinnamon: An imperative spice for human comfort. Int J Pharm Res Bio Sci 2013;2:131-45.

Risikobewertung BF. High Daily Intakes of Cinnamon: Health Risk Cannot be Ruled Out. BfR Health Assessment No. 044/2006. Germany: Bundesinstitut Für Risikobewertung; 2006.

Abraham K, Wöhrlin F, Lindtner O, Heinemeyer G, Lampen A. Toxicology and risk assessment of coumarin: Focus on human data. Mol Nutr Food Res 2010;54:228-39.

Paranagama PA, Wimalasena S, Jayatilake GS, Jayawardena AL, Senanayake UM, Mubarak AM. A comparison of essential oil constituents of bark, leaf, root and fruit of cinnamon (Cinnamomum zeylanicum Blum) grown in Sri Lanka. J Nat Sci Found Sri Lanka 2001;29:147-53.

Jayaprakasha GK, Rao LJ. Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum. Crit Rev Food Sci Nutr 2011;51:547-62.

Singletary K. Cinnamon: Overview of health benefits. Nutr Today 2008;43:263-6.

Baratta MT, Dorman HD, Deans SG, Figueiredo AC, Barroso JG, Ruberto G. Antimicrobial and antioxidant properties of some commercial essential oils. Flavour Fragr J 1998;13:235-44.

Ranasinghe P, Pigera S, Premakumara GS, Galappaththy P, Constantine GR, Katulanda P. Medicinal properties of ‘true’cinnamon (Cinnamomum zeylanicum): A systematic review. BMC Complementary Altern Med 2013;13:275.

Elumalai S, Kesavan R, Ramganesh S, Prakasam V, Murugasen R. Comparative study on anti-microbial activities of bark oil extract from Cinnamomum cassia and Cinnamomum zeylanicum. Biosc Biotechnol Res Asia 2010;7:251-8.

Ranasinghe P, Galappaththy P. Health benefits of ceylon cinnamon (Cinnamomum zeylanicum): A summary of the current evidence. Ceylon Med J 2016;61:1-5.

Lee SH, Lee SY, Son DJ, Lee H, Yoo HS, Song S, et al. Inhibitory effect of 2′-hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-κB activation in raw 264.7 cells. Biochem Pharm 2005;69:791-9.

Hwang SH, Choi YG, Jeong MY, Hong YM, Lee JH, Lim S, et al. Microarray analysis of gene expression profile by treatment of Cinnamomi ramulus in lipopolysaccharide-stimulated BV-2 cells. Gene 2009;443:83-90.

Khan A, Bryden NA, Polansky MM, Anderson RA. Insulin potentiating factor and chromium content of selected foods and spices. Biol Trace Elem Res 1990;24:183-8.

Broadhurst CL, Polansky MM, Anderson RA. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem 2000;48:849-52.

Kreydiyyeh SI, Usta J, Copti R. Effect of cinnamon, clove and some of their constituents on the na(+)-K(+)-ATPase activity and alanine absorption in the rat jejunum. Food Chem Toxicol 2000;38:755-62.

Cao H, Polansky MM, Anderson RA. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys 2007;459:214-22.

Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. Volatile constituents from Cinnamomum zeylanicum fruit stalks and their antioxidant activities. J Agric Food Chem 2003;51:4344-8.

Yu SM, Ko FN, Wu TS, Lee JY, Teng CM. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense. Eur J Pharmacol 1994;256:85-91.

Lee EJ, Chen HY, Hung YC, Chen TY, Lee MY, Yu SC, et al. Therapeutic window for cinnamophilin following oxygen-glucose deprivation and transient focal cerebral ischemia. Exp Neurol 2009;217:74-83.

Khasnavis S, Pahan K. Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective parkinson disease protein DJ-1 in astrocytes and neurons. J Neuroimmune Pharmacol 2012;7:424-35.

Kim SH, Hyun SH, Choung SY. Anti-diabetic effect of cinnamon extract on blood glucose in Db/Db mice. J Ethnopharmacol 2006;104:119-23.

Chen L, Yang Y, Yuan P, Yang Y, Chen K, Jia Q, et al. Immunosuppressive effects of A-type procyanidin oligomers from Cinnamomum tamala. Evid Based Complement Alternat Med 2014;2014:365258.

Lu J, Zhang K, Nam S, Anderson RA, Jove R, Wen W, et al. Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling. Carcinogenesis 2010;31:481-8.

Jeong HW, Han DC, Son KH, Han MY, Lim JS, Ha JH, et al. Antitumor effect of the cinnamaldehyde derivative CB403 through the arrest of cell cycle progression in the G2/M phase. Biochem Pharmacol 2003;65:1343-50.

Cabello CM, Bair WB 3rd, Lamore SD, Ley S, Bause AS, Azimian S, et al. The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. Free Radic Biol Med 2009;46:220-31.


  • There are currently no refbacks.